Abstract:<p>The complement system was discovered at the end of the 19th century as a heat-labile plasma component that "complemented" the antibodies in killing microbes, hence the name "complement." Complement is also part of the innate immune system, protecting the host by recognition of pathogen-associated molecular patterns. However, complement is multifunctional far beyond infectious defense. It contributes to organ development, such as sculpting neuron synapses, promoting tissue regeneration and repair, and rapidly engaging and synergizing with a number of processes, including hemostasis leading to thromboinflammation. Complement is a double-edged sword. Although it usually protects the host, it may cause tissue damage when dysregulated or overactivated, such as in the systemic inflammatory reaction seen in trauma and sepsis and severe coronavirus disease 2019 (COVID-19). Damage-associated molecular patterns generated during ischemia-reperfusion injuries (myocardial infarction, stroke, and transplant dysfunction) and in chronic neurologic and rheumatic disease activate complement, thereby increasing damaging inflammation. Despite the long list of diseases with potential for ameliorating complement modulation, only a few rare diseases are approved for clinical treatment targeting complement. Those currently being efficiently treated include paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, myasthenia gravis, and neuromyelitis optica spectrum disorders. Rare diseases, unfortunately, preclude robust clinical trials. The increasing evidence for complement as a pathogenetic driver in many more common diseases suggests an opportunity for future complement therapy, which, however, requires robust clinical trials; one ongoing example is COVID-19 disease. The current review aims to discuss complement in disease pathogenesis and discuss future pharmacological strategies to treat these diseases with complement-targeted therapies.</p>Significance Statement<p>The complement system is the host's defense friend by protecting it from invading pathogens, promoting tissue repair, and maintaining homeostasis. Complement is a double-edged sword, since when dysregulated or overactivated it becomes the host's enemy, leading to tissue damage, organ failure, and, in worst case, death. A number of acute and chronic diseases are candidates for pharmacological treatment to avoid complement-dependent damage, ranging from the well established treatment for rare diseases to possible future treatment of large patient groups like the pandemic coronavirus disease 2019.</p>

Complement system activation: bridging physiology, pathophysiology, and therapy

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics

Complement in disease: a defence system turning offensive

The complement system: A key player in the host response to infections

Complement System Part II: Role in Immunity

The state of complement in COVID-19

Complement: a key system for immune surveillance and homeostasis

Implications of Complement Imbalance in COVID-19: A Molecular Mechanistic Discussion on the Importance of Complement Balance

The dysfunction of complement and coagulation in diseases: the implications for the therapeutic interventions

The complement system in systemic autoimmune disease.

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

ԿՈՄՊԼԵՄԵՆՏԻ ՀԱՄԱԿԱՐԳԻ ԴԵՐԸ ԱԿՆԱՅԻՆ ՊԱԹՈԼՈԳԻԱՆԵՐԻ ԷԹԻՈՊԱԹՈԳԵՆԵԶՈՒՄ (ՏԵՍՈՒԹՅԱՆ ՎԵՐԼՈՒԾՈՒԹՅՈՒՆ)

Immunodeficiency: Complement disorders

Complement as a target in COVID-19?

The complement system and autoimmune diseases

Local complement activation and modulation in mucosal immunity

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases

Clinical promise of next-generation complement therapeutics

Complement in neurological disorders and emerging complement-targeted therapeutics

The complement system in neurodegenerative and inflammatory diseases of the central nervous system

New topic of complement and diseases